Latent tuberculosis infection and non-infectious co-morbidities: Diabetes mellitus type 2, chronic kidney disease and rheumatoid arthritis
File(s) 1-s2.0-S1201971219300827-main.pdf (303.01 KB)
Published version
Author(s)
Ugarte-Gil, Cesar
Carrillo-Larco, Rodrigo M
Kirwan, Daniela E
Type
Journal Article
Abstract
The prevalence of non-communicable diseases is increasing worldwide, which coincides with the persistence of infectious diseases including tuberculosis. These can synergistically affect individual and population health. Three non-communicable diseases that are relevant because of their associated morbidity, mortality and disability are type 2 diabetes mellitus, chronic kidney disease and rheumatoid arthritis. There is some evidence that patients with these conditions are at increased risk of acquiring latent tuberculosis infection (LTBI) and of this progressing to active disease. Unfortunately, evidence on accurate testing and effective prophylactic treatment in these populations is lacking. This review discusses current evidence and recommendations for management of LTBI in these patients.
Date Issued
2019-03-01
Date Acceptance
2019-02-18
Citation
International Journal of Infectious Diseases, 2019, 80 (Supplement), pp.29-31
ISSN
1201-9712
Publisher
Elsevier
Start Page
29
End Page
31
Journal / Book Title
International Journal of Infectious Diseases
Volume
80
Issue
Supplement
Copyright Statement
© 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000460660800008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Infectious Diseases
Tuberculosis
Diabetes mellitus type 2
Chronic kidney disease and Rheumatoid arthritis
RISK
PULMONARY
Publication Status
Published
Date Publish Online
2019-02-22
